ZSQR
Z Squared Inc.
Company overview
- Market capitalization
- $233.50M
- Employees
- —
- Latest publication
- 2026-09-29
About Z Squared Inc.
Z Squared Inc. an integrated computing infrastructure company, operates advanced computing equipment distributed across North Carolina, South Carolina, and Iowa. The company manages and optimizes a fleet of specialized computing hardware, supported by dynamic power management strategies, real time analytics dashboards, and a comprehensive in house repair and lifecycle management program designed to maximize hardware efficiency and reduce capital waste. The company was founded in 2022 and is based in Fort Lauderdale, Florida.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,583,485USD | 113,771USD | 862,049USD | 237,441USD | 200,681USD | 62,874USD | — | — |
| Cost Of Revenue | 3,349,432USD | 45,156USD | 987,564USD | 45,155USD | 45,157USD | 1,359,708USD | 259,982USD | 278,229USD |
| Gross Profit | -1,765,947USD | 68,615USD | -125,514USD | 192,286USD | 155,524USD | -1,296,834USD | -259,982USD | -278,229USD |
| Selling And Marketing Expenses | 9,739USD | 0USD | — | — | — | — | — | — |
| Total Operating Expenses | 12,028,653USD | 3,983,259USD | 1,862,757USD | 2,669,314USD | 4,676,738USD | 2,760,149USD | 1,902,232USD | 1,863,560USD |
| Operating Income | -13,794,600USD | -3,914,644USD | -1,988,272USD | -2,477,028USD | -4,521,214USD | -4,056,984USD | -2,162,214USD | -2,141,789USD |
| Total Other Income Expense Net | -145USD | -106,252USD | 365,370USD | -421,735USD | 186,628USD | 636,043USD | -849,551USD | 312,875USD |
| Interest Expense | 226USD | 5,257USD | 440,490USD | 62,610USD | 67,788USD | 71,491USD | 78,629USD | 50,926USD |
| Income Before Tax | -13,794,745USD | -4,020,896USD | -1,622,902USD | -2,898,763USD | -4,334,586USD | -3,420,941USD | -3,011,765USD | -1,828,914USD |
| Income Tax Expense | 0USD | 0USD | — | 0USD | 0USD | — | — | — |
| Net Income | -13,722,495USD | -3,916,618USD | -1,577,869USD | -2,898,763USD | -4,334,586USD | -3,057,730USD | -3,011,765USD | -1,828,914USD |
| Minority Interest | 72,250USD | 104,278USD | — | 159,360USD | 799,991USD | 64,403USD | — | — |
| Net Income Applicable To Common Shares | -13,722,495USD | -4,020,896USD | — | — | — | — | — | — |
| Research Development | — | 235,529USD | 312,903USD | 587,279USD | 290,309USD | 86,659USD | 343,878USD | 811,784USD |
| Unclassified Operating Expenses | — | — | 1,549,854USD | — | — | -1,064,553USD | 1,558,354USD | 1,051,776USD |
| Ebit | — | — | -1,988,272USD | — | — | -4,056,984USD | -2,162,214USD | -2,141,789USD |
| Ebitda | — | — | -1,682,264USD | — | — | -3,751,687USD | -1,902,232USD | -1,863,560USD |
| Depreciation And Amortization | — | — | 306,008USD | — | — | 305,297USD | 259,982USD | 278,229USD |
| Selling General Administrative | — | — | — | 201,132USD | 527,003USD | 3,738,043USD | — | — |
| General And Administrative Expenses | — | — | — | 201,132USD | 527,003USD | — | — | — |
| Net Interest Income | — | — | — | — | — | -71,491USD | — | — |
| Tax Provision | — | — | — | — | — | 0USD | — | — |
| Net Income From Continuing Ops | — | — | — | — | — | -3,420,941USD | — | — |
| Reconciled Depreciation | — | — | — | — | — | 305,297USD | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 1,363,045USD | 0USD | 0USD | — | 75,000USD | — |
| Cost Of Revenue | 180,625USD | 1,038,632USD | 1,001,236USD | 1,001,384USD | 447,413USD | — |
| Gross Profit | 1,182,420USD | -1,038,632USD | -1,001,236USD | -1,001,384USD | -372,413USD | — |
| Research Development | 1,277,150USD | 2,331,548USD | 6,668,244USD | 20,887USD | — | — |
| Selling And Marketing Expenses | 105,000USD | — | — | — | — | — |
| Total Operating Expenses | 14,225,918USD | 9,015,855USD | 20,489,888USD | 33,194,580USD | 13,673,519USD | 68,430USD |
| Operating Income | -13,043,498USD | -10,054,488USD | -21,491,125USD | -34,195,964USD | -14,045,932USD | -68,430USD |
| Total Other Income Expense Net | 766,306USD | -822,924USD | 224,588USD | -3,378,253USD | 596,652USD | -17,211,346USD |
| Interest Expense | 96,744USD | 462,305USD | 107,685USD | 218,412USD | 187,133USD | — |
| Income Before Tax | -12,277,192USD | -10,877,412USD | -21,266,537USD | -37,574,217USD | -13,449,280USD | -17,279,776USD |
| Income Tax Expense | 0USD | — | — | — | — | — |
| Net Income | -12,277,192USD | -10,680,452USD | -21,266,537USD | -37,574,217USD | -13,449,280USD | -17,279,776USD |
| Minority Interest | -360,177USD | — | — | — | — | — |
| Net Income Applicable To Common Shares | -11,917,015USD | — | — | — | — | — |
| Selling General Administrative | — | 60USD | 60USD | — | — | — |
| Unclassified Operating Expenses | — | 6,684,247USD | 13,821,584USD | 33,173,693USD | 13,673,519USD | — |
| Tax Provision | — | 0USD | 0USD | — | — | — |
| Net Income From Continuing Ops | — | -60USD | -60USD | — | — | — |
| Ebit | — | -10,054,488USD | -21,491,125USD | -34,195,964USD | -14,045,932USD | — |
| Ebitda | — | -9,015,856USD | -20,489,889USD | -33,194,580USD | -13,598,519USD | -68,430USD |
| Depreciation And Amortization | — | 1,038,632USD | 1,001,236USD | 1,001,384USD | 447,413USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 134,509,962USD | 19,786,693USD | 16,153,921USD | 14,181,641USD | 12,191,479USD | 13,703,067USD | 11,008,660USD | 11,055,984USD |
| Cash And Equivalents | 15,492,446USD | — | — | — | — | — | — | — |
| Total Current Assets | 15,525,787USD | 5,908,108USD | 7,350,149USD | 5,990,862USD | 3,694,935USD | 4,650,996USD | 1,051,292USD | 1,364,674USD |
| Total Liabilities | 2,026,554USD | 2,207,849USD | 2,085,764USD | 3,264,864USD | 5,111,349USD | — | — | — |
| Total Current Liabilities | 2,026,554USD | 1,817,319USD | 1,768,139USD | 2,705,364USD | 4,475,225USD | 5,652,154USD | 4,513,309USD | 3,440,263USD |
| Other Current Liabilities | 120,120USD | 120,000USD | 120,000USD | 120,000USD | 235,000USD | — | — | — |
| Total Stockholder Equity | 132,483,408USD | 17,176,959USD | 13,561,994USD | 10,365,582USD | 6,095,830USD | 6,728,614USD | 5,285,164USD | 6,924,733USD |
| Total Equity Including Noncontrolling Interest | 132,483,408USD | 17,578,844USD | 14,068,157USD | 10,916,777USD | 7,080,130USD | — | — | — |
| Property Plant Equipment Net | 11,281,391USD | 98,978USD | 28,272USD | 39,124USD | 49,731USD | 60,102USD | 70,243USD | 80,226USD |
| Goodwill | 106,932,241USD | — | — | — | — | — | — | — |
| Accounts Payable | 1,382,047USD | 1,011,172USD | 888,755USD | 783,103USD | 1,028,826USD | 1,120,657USD | 1,269,763USD | 1,134,243USD |
| Common Stock | 5,300USD | 656USD | 575USD | 516USD | 416USD | 337USD | 212USD | 3,996USD |
| Retained Earnings | -13,722,968USD | -113,870,346USD | -109,953,728USD | -108,375,858USD | -105,989,201USD | -101,654,614USD | -98,233,673USD | -95,221,907USD |
| Short Term Investments | — | 50,551USD | 676,596USD | 421,698USD | 990,566USD | — | — | — |
| Long Term Debt | — | 150,000USD | 150,000USD | 150,000USD | 150,000USD | — | — | — |
| Deferred Revenue | — | 485,684USD | 599,455USD | 1,461,504USD | 1,631,445USD | — | — | — |
| Intangible Assets | — | 316,094USD | 361,250USD | 406,406USD | 451,563USD | 1,800,886USD | 2,096,041USD | 1,804,167USD |
| Short Term Debt | — | 40,323USD | 18,875USD | 29,865USD | 21,738USD | 1,871,435USD | 1,230,178USD | 1,563,819USD |
| Net Receivables | — | — | — | 82,500USD | 30,000USD | — | — | — |
| Other Current Assets | — | — | — | — | — | 382,628USD | 518,406USD | 227,221USD |
| Total Liab | — | — | — | — | — | 5,990,153USD | 5,041,434USD | 3,973,567USD |
| Other Current Liab | — | — | — | — | — | 2,660,062USD | 2,013,368USD | 742,201USD |
| Capital Stock | — | — | — | — | — | 0USD | — | — |
| Cash | — | — | — | — | — | 4,268,368USD | 532,885USD | 1,137,453USD |
| Cash And Short Term Investments | — | — | — | — | — | 4,268,368USD | 532,885USD | 1,137,453USD |
| Net Debt | — | — | — | — | — | -2,228,059USD | 866,168USD | 637,545USD |
| Short Long Term Debt Total | — | — | — | — | — | 2,040,309USD | 1,399,053USD | 1,774,998USD |
| Common Stock Shares Outstanding | — | — | — | — | — | 3,073,074shares | 2,116,191shares | 1,990,325shares |
| Non Current Assets Total | — | — | — | — | — | 9,052,071USD | 9,957,368USD | 9,691,310USD |
| Non Current Liabilities Total | — | — | — | — | — | 337,998USD | 528,125USD | 533,304USD |
| Net Working Capital | — | — | — | — | — | -120USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | 7,191,083USD | 7,791,084USD | 7,791,084USD |
| Unclassified Equity | — | — | — | — | — | 108,382,891USD | 102,976,750USD | 102,142,644USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | 541,875USD | — |
| Non Currrent Assets Other | — | — | — | — | — | — | — | 15,833USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 16,153,921USD | 11,008,660USD | 8,071,089USD | 7,915,689USD | 6,765,576USD | 76,710,203USD | 171,545USD |
| Short Term Investments | 676,596USD | — | — | — | — | — | — |
| Total Current Assets | 7,350,149USD | 1,051,292USD | 1,749,713USD | 3,941,733USD | 2,179,558USD | 958,999USD | 505USD |
| Total Liabilities | 2,085,764USD | — | — | — | — | — | — |
| Total Current Liabilities | 1,768,139USD | 4,513,309USD | 2,988,696USD | 2,172,637USD | 2,764,942USD | 5,000USD | 155,852USD |
| Other Current Liabilities | 120,000USD | — | — | — | — | — | — |
| Total Stockholder Equity | 13,561,994USD | 5,482,124USD | 4,313,964USD | 4,453,329USD | 2,350,634USD | 53,755,203USD | 15,692USD |
| Total Equity Including Noncontrolling Interest | 14,068,157USD | — | — | — | — | — | — |
| Long Term Debt | 150,000USD | — | — | — | — | — | — |
| Deferred Revenue | 599,455USD | — | — | — | — | — | — |
| Property Plant Equipment Net | 28,272USD | 70,243USD | 108,877USD | 71,456USD | 31,850USD | — | — |
| Intangible Assets | 361,250USD | 2,096,041USD | 2,554,166USD | 3,554,167USD | 4,554,167USD | — | — |
| Accounts Payable | 888,755USD | 1,269,763USD | 1,419,699USD | 99,021USD | 134,092USD | — | 450USD |
| Short Term Debt | 18,875USD | 1,230,178USD | 1,013,047USD | 1,891,618USD | 2,431,724USD | — | 152,644USD |
| Common Stock | 575USD | 212USD | 3,533USD | 1,957USD | 1,196USD | 75,776,204USD | 25,000USD |
| Retained Earnings | -109,953,728USD | -98,036,713USD | -87,356,260USD | -66,089,723USD | -27,550,126USD | -22,021,000USD | -9,307USD |
| Other Current Assets | — | 518,406USD | 241,601USD | 142,356USD | — | 51,815USD | — |
| Total Liab | — | 5,041,434USD | 3,757,125USD | 3,462,360USD | 4,414,942USD | 22,955,000USD | 155,852USD |
| Other Current Liab | — | 2,013,368USD | 555,950USD | 181,998USD | 199,126USD | 5,000USD | — |
| Capital Stock | — | 0USD | 0USD | — | — | — | — |
| Cash | — | 532,885USD | 1,469,134USD | 3,791,302USD | 2,179,558USD | 907,184USD | 505USD |
| Cash And Short Term Investments | — | 532,885USD | 1,469,134USD | 3,791,302USD | 2,179,558USD | 907,184USD | 505USD |
| Net Debt | — | 866,168USD | -244,908USD | -1,734,961USD | 1,902,166USD | -907,184USD | 152,139USD |
| Short Long Term Debt Total | — | 1,399,053USD | 1,224,226USD | 2,056,341USD | 4,081,724USD | — | 152,644USD |
| Accumulated Other Comprehensive Income | — | 541,875USD | — | — | — | — | — |
| Common Stock Shares Outstanding | — | 1,924,639shares | 1,284,499shares | 714,783shares | 545,728shares | 468,750shares | — |
| Non Current Assets Total | — | 9,957,368USD | 6,321,376USD | 3,973,956USD | 4,586,018USD | 75,751,204USD | 171,040USD |
| Non Current Liabilities Total | — | 528,125USD | 768,428USD | 1,289,723USD | 1,650,000USD | 22,950,000USD | — |
| Net Working Capital | — | -120USD | -60USD | — | — | — | — |
| Unclassified Non Current Assets | — | 7,791,084USD | 3,500,000USD | — | — | 75,751,204USD | — |
| Unclassified Equity | — | 102,976,750USD | 91,666,691USD | 70,541,095USD | 29,899,564USD | — | — |
| Net Receivables | — | — | 38,978USD | 8,075USD | — | — | — |
| Non Currrent Assets Other | — | — | 158,333USD | 348,333USD | — | — | 171,040USD |
| Unclassified Non Current Liabilities | — | — | — | 1,289,723USD | 1,650,000USD | 22,950,000USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | 2,758USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD |
|---|---|---|---|
| Depreciation | 1,157,509USD | 885,909USD | 590,606USD |
| Stock Based Compensation | 7,033,939USD | — | — |
| Change To Liabilities | 524,387USD | -525,642USD | -320,675USD |
| Operating Cash Flow | -202,795USD | -6,915,126USD | -4,762,909USD |
| Net Investments | 0USD | — | — |
| Investing Cash Flow | 0USD | 0USD | 0USD |
| Financing Cash Flow | 15,693,839USD | 11,290,728USD | 6,226,750USD |
| Change In Cash | 15,491,044USD | 4,375,602USD | 1,463,841USD |
| End Cash Flow | 15,492,446USD | 4,908,487USD | 1,996,726USD |
| Other Non Cash Items | — | -135,055USD | -135,055USD |
| Change To Account Receivables | — | -82,500USD | -30,000USD |
| Change In Working Capital | — | -470,996USD | -248,555USD |
| Common Stock Issuance | — | — | 0USD |
| Unclassified Financing Cash Flow | — | — | 6,226,750USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 295,302USD | 306,008USD | 305,765USD | 305,527USD | 305,297USD | 259,982USD | 278,229USD | 250,211USD |
| Stock Based Compensation | 1,079,436USD | — | — | — | 597,731USD | — | — | — |
| Change To Liabilities | 19,086USD | — | — | — | — | — | — | — |
| Operating Cash Flow | -1,758,887USD | — | — | — | — | — | — | — |
| Net Investments | 591,519USD | — | — | — | — | — | — | — |
| Investing Cash Flow | 591,519USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 704,254USD | — | — | — | — | — | — | — |
| Change In Cash | -463,114USD | 765,815USD | 2,911,761USD | -2,271,642USD | 3,735,483USD | -604,568USD | -417,622USD | 525,831USD |
| End Cash Flow | 5,211,188USD | — | — | — | — | — | — | — |
| Net Income | — | -1,577,869USD | -2,739,403USD | -3,534,595USD | -3,057,730USD | -3,011,765USD | -1,828,914USD | -3,035,345USD |
| Other Non Cash Items | — | -525,851USD | 861,301USD | 1,601,545USD | 607,021USD | 1,359,538USD | -203,112USD | 1,396,420USD |
| Change To Account Receivables | — | 78,693USD | -56,041USD | -30,000USD | — | — | — | — |
| Change In Working Capital | — | 109,802USD | -579,880USD | -769,219USD | -220,755USD | -44,293USD | -138,825USD | -29,017USD |
| Total Cash From Operating Activities | — | -1,687,910USD | -2,152,217USD | -2,396,742USD | -2,366,167USD | -1,436,538USD | -1,892,622USD | -1,417,731USD |
| Capital Expenditures | — | 0USD | -3USD | 0USD | -3USD | 0USD | 0USD | 0USD |
| Free Cash Flow | — | -1,687,910USD | -2,152,220USD | -2,396,740USD | -2,366,170USD | -1,436,540USD | -1,892,620USD | -1,417,730USD |
| Total Cash From Financing Activities | — | 2,453,725USD | 5,063,978USD | 125,099USD | 6,101,650USD | 731,971USD | 1,474,999USD | 1,943,562USD |
| Begin Period Cash Flow | — | 4,908,487USD | 1,996,726USD | 4,268,368USD | 532,885USD | 1,137,453USD | 1,555,075USD | 1,029,244USD |
| End Period Cash Flow | — | 5,674,302USD | 4,908,487USD | 1,996,726USD | 4,268,368USD | 532,885USD | 1,137,453USD | 1,555,075USD |
| Investments | — | — | — | — | 0USD | — | — | — |
| Net Borrowings | — | — | — | — | 771,250USD | — | — | — |
| Issuance Of Capital Stock | — | — | — | — | 5,330,000USD | — | — | — |
| Total Cashflows From Investing Activities | — | — | — | — | — | 100,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 100,000USD | — | — |
| Other Cashflows From Financing Activities | — | — | — | — | — | 100,000USD | -50,000USD | 50,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | 1,524,999USD | 1,893,562USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Depreciation | 1,181,212USD | 1,038,632USD | 1,001,236USD | 1,001,384USD | 447,413USD | — |
| Other Non Cash Items | 159,035USD | 3,117,801USD | 11,264,151USD | 33,247,357USD | 11,492,123USD | 16,886,364USD |
| Change To Liabilities | -555,889USD | — | — | — | — | — |
| Operating Cash Flow | -8,603,036USD | — | — | — | — | — |
| Investing Cash Flow | 0USD | — | — | — | — | — |
| Financing Cash Flow | 13,744,453USD | — | — | — | — | — |
| Change In Cash | 5,141,417USD | -936,249USD | -2,322,168USD | 1,611,744USD | 1,272,374USD | 906,679USD |
| End Cash Flow | 5,674,302USD | — | — | — | — | — |
| Net Income | — | -10,680,452USD | -21,266,537USD | -37,574,217USD | -13,449,280USD | -17,279,776USD |
| Change To Account Receivables | — | -234,742USD | -30,903USD | -8,075USD | 21,786USD | — |
| Change In Working Capital | — | -125,262USD | 1,761,636USD | -550,335USD | -2,979,696USD | -47,265USD |
| Total Cash From Operating Activities | — | -6,649,281USD | -7,239,514USD | -3,875,811USD | -4,489,440USD | -440,677USD |
| Capital Expenditures | — | 0USD | -4USD | 0USD | 0USD | -3USD |
| Free Cash Flow | — | -6,649,280USD | -7,239,510USD | -3,875,810USD | -4,489,440USD | -440,680USD |
| Total Cash From Financing Activities | — | 5,713,032USD | 4,917,346USD | 5,487,555USD | 8,216,032USD | 77,097,356USD |
| Begin Period Cash Flow | — | 1,469,134USD | 3,791,302USD | 2,179,558USD | 907,184USD | 505USD |
| End Period Cash Flow | — | 532,885USD | 1,469,134USD | 3,791,302USD | 2,179,558USD | 907,184USD |
| Other Cashflows From Financing Activities | — | — | 700,000USD | -614,580USD | -50,898USD | — |
| Unclassified Financing Cash Flow | — | — | 4,217,346USD | 6,102,135USD | 8,514,095USD | — |
| Total Cashflows From Investing Activities | — | — | — | — | -1,750,000USD | -75,750,000USD |
| Sale Purchase Of Stock | — | — | — | — | -247,165USD | — |
| Unclassified Investing Cash Flow | — | — | — | — | -1,750,000USD | -75,749,997USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Segment | Biotechnology | 0 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Technology | 113,771 | USD | Disclosure |
| Q4 2025Quarterly · 2025-12-31 | Segment | Biotechnology | 0 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Technology | 862,049 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Sale — Advertising Campaigns | 1,250,545 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Product | Sale — Webinar Services | 112,500 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Segment | Biotechnology | 0 | USD | Disclosure |
| FY 2025Yearly · 2025-12-31 | Segment | Technology | 1,363,045 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Segment | Biotechnology | 0 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Segment | Technology | 237,441 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Product | Sale — Advertising Campaigns | 169,941 | USD | Disclosure |
| Q3 2025Quarterly · 2025-09-30 | Product | Sale — Webinar Services | 67,500 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Segment | Biotechnology | 0 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Segment | Technology | 200,681 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Product | Sale — Advertising Campaigns | 155,681 | USD | Disclosure |
| Q2 2025Quarterly · 2025-06-30 | Product | Sale — Webinar Services | 45,000 | USD | Disclosure |
| FY 2021Yearly · 2021-12-31 | Product | Consulting Services | 75,000 | USD | 0001683168-23-001850 |
| FY 2021Yearly · 2021-12-31 | Product | Other Sales | 0 | USD | 0001683168-23-001850 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.